The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Metabolic Messengers: bile acids
Open accessAbstract
Bile acids (BAs) are amphipathic steroid acids whose production and diversity depend on both host and microbial metabolism. These metabolites have emerged as biologically active signalling molecules that inform organs of nutrient availability. Their actions, through activation of the dedicated BA receptors FXR and TGR5, control the body’s integrated physiological metabolic responses. Alterations in BA abundance or signalling are associated with metabolic diseases including obesity, type 2 diabetes, non-alcoholic steatohepatitis and atherosclerosis. Consequently, modulation of the BA pool could be a valid therapeutic approach, as demonstrated in preclinical and clinical models. Here we provide a historical summary of the discovery of BAs and their receptors, as well as a summary on the role of BA signalling in the control of energy homeostasis. Perino and Schoonjans summarize the most recent literature on the receptor-mediated role of bile acid signalling in the control of peripheral and central energy homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peripheral BAs provide signals to the CNS indirectly via TGR5-dependent glucagon-like peptide-1 (GLP-1) pathway and the FXR-dependent fibroblast growth factor 15 or 19 (FGF15/19) pathway.350”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [350]
In the citing paper
“However, non-reabsorbed primary BAs are converted by the gut microbiota into secondary BAs (deoxycholic acid, DCA, and lithocholic acid, LCA) via deconjugation and dehydroxylation, endowing them with new biological activities.20,350”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [350]
In the citing paper
“Notably, the modification of gut microbiota, BA metabolism and activation of intestinal TGR5 by dioscin treatment led to enhanced secretion of GLP-1 in both the intestine and brain of MPTP-treated mice. This is coupled with reduced glial activation and amelioration of motor deficits.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [350]
Citations
Cites
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,969
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997) · Nature · doi:10.1038/385165a0 · Cited by 1,924
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
Research works printed but not linked: 1
- Bryan, C. P. The Papyrus Ebers. (Appleton, New York, 1931).
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 993
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 356
A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage
Li, T., Ding, N., Guo, H., Hua, R., Lin, Z., Tian, H., Yu, Y., Fan, D., Yuan, Z., Gonzalez, F. J., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.015 · Cited by 157
Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort
Goodrich, J. A., Walker, D. I., Lin, X., Wang, H., Lim, T., McConnell, R., Conti, D. V., Chatzi, L., & Setiawan, V. W. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100550 · Cited by 144
Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy
Wang, H., Wang, J., Cui, H., Fan, C., Xue, Y., Liu, H., Li, H., Li, J., Li, H., Sun, Y., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01036-5 · Cited by 136
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 132
Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling
Wang, Q., Lin, H., Shen, C., Zhang, M., Wang, X., Yuan, M., Yuan, M., Jia, S., Cao, Z., Wu, C., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2274124 · Cited by 126
“39,40 Previous studies have shown that secondary bile acids and primary unconjugated bile acids decreases while primary taurine-conjugated bile acids mainly TCA and TβMCA increases in the serum or small intestine of antibiotic-treated mice 27 and GF mice.”
BackgroundThe potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 131
A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation
Randeni, N., Bordiga, M., & Xu, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179366 · Cited by 115
Song, L., Hou, Y., Xu, D., Dai, X., Luo, J., Liu, Y., Huang, Z., Yang, M., Chen, J., Hu, Y., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.008 · Cited by 91
The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 107
“TGR5 is widely expressed across various tissues, particularly in gallbladder epithelial cells, where it is most abundant [52].”
Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
Gao, R., Meng, X., Xue, Y., Mao, M., Liu, Y., Tian, X., Sui, B., Li, X., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027212 · Cited by 86
“In addition, BAs act as the significant signaling molecules in the regulation of energy homeostasis to activate different receptors, which play an important role in pathogenesis of T2DM (Perino and Schoonjans, 2022).”
BackgroundGut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s Disease
Zhu, G., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.005 · Cited by 78
“Once secreted into the intestine and colon, they are further modified by gut bacteria (secondary bile acids) through dihydroxylation and deconjugation [85].”
BackgroundMicrobiome and Allergy: New Insights and Perspectives
Zubeldia‐Varela, E., Barker‐Tejeda, T. C., Obeso, D., Villaseñor, A., Barber, D., & Pérez‐Gordo, M. (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0852 · Cited by 60
Bile acids metabolism in the gut-liver axis mediates liver injury during lactation
Huang, L. S., Li, Y., Tang, R., Yang, P., Zhuo, Y., Jiang, X., Che, L., Lin, Y., Xu, S., Li, J., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122380 · Cited by 53
Bile acid metabolism in type 2 diabetes mellitus
Sandoval, M. C., & Haeusler, R. A. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01067-8 · Cited by 54
Wu, Y., Zheng, Y., Wang, X., Tang, P., Guo, W., Ma, H., Zhang, A., Li, D., Xie, Y., Wang, C., et al. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500325 · Cited by 51
Identification of gut microbial bile acid metabolic enzymes via an AI-assisted pipeline
Ding, Y., Luo, X., Guo, J., Xing, B., Lin, H., Ma, H., Wang, Y., Li, M., Ye, C., Yan, S. R., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.017 · Cited by 54
Liu, A., Xu, C., Liu, Y., Sun, D., Jiang, L., Tang, L., Zhu, P., Chen, S., Liu, W., Wang, X., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17362 · Cited by 44
“BAs carry out their important digestive functions aiding in the absorption of fats and fat-soluble vitamins (13).”
Chen, Y., Pei, C., Chen, Y., Xiao, X., Zhang, X., Cai, K., Deng, S., Liang, R., Xie, Z., Li, P., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110449 · Cited by 41
Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
Yue, X., Zhou, H., Wang, S., Chen, X., & Xiao, H. (2024) · Cancer Medicine · doi:10.1002/cam4.6799 · Cited by 45
“…Studies have shown that primary and secondary BAs act as signaling molecules to target BA receptors in host immune cells (e.g., farnesoid X receptor and the G- protein-coupled receptor TGR5), 109 downregulate TNF-α and IL-12 in DCs and monocytes, and increase the production of IL-10 in macrophages.”
BackgroundYang, C., Huang, S., Lin, Z., Chen, H., Xu, C., Lin, Y., Sun, H., Huang, F., Dai, L., & Guo, F. (2022) · Food & Function · doi:10.1039/d2fo02079c · Cited by 38
Wahlstrom, A. M., Aydin, Ö., Olsson, L. M., Sjöland, W., Henricsson, M., Lundqvist, A., Marschall, H., Franken, R. J., van de Laar, A. W. J. M., Gerdes, V. E. A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105265 · Cited by 37
“38 Taurine-or glycine-conjugated bile acids demonstrated clear postprandial responses before surgery, which is consistent with the common concept of conjugated bile acids being absorbed via the ileal bile acid transporter (IBAT) in the distal ileum before entering the enterohepatic circulation and…”
Integrative systems analysis identifies genetic and dietary modulators of bile acid homeostasis
Li, H., Perino, A., Huang, Q. D., von Alvensleben, G., Banaei‐Esfahani, A., Velázquez‐Villegas, L. A., Gariani, K., Korbelius, M., Sleiman, M. S. B., Imbach, J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.015 · Cited by 33
Self-citationZhang, L., Shi, J., Shen, Q., Fu, Y., Qi, S., Wu, J., Chen, J., Zhang, H., Mu, Y., Chen, G., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116833 · Cited by 35
Chen, N., Chan, C. K., Khan, F. U., Makhijani, P., Valentino, T. R., Winer, S., Luk, C. T., & Winer, D. A. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103036 · Cited by 37
Cai, T., Song, X., Xu, X., Dong, L., Liang, S., Xin, M., Huang, Y., Zhu, L., Li, T., Wang, X., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1323261 · Cited by 32
“…(FXR), vitamin D receptor (VDR), pregnane X receptor (PXR) and the membrane-bound G protein-coupled receptor Takeda G protein-coupled receptor 5 (TGR5), which exert essential effects to regulate the balance of BA metabolism, glycolipid metabolism and energy metabolism (Perino and Schoonjans, 2022).”
BackgroundImpact of the gut microbiome on atherosclerosis
Mao, Y., Kong, C., Zang, T., You, L., Wang, L., Shen, L. W., & Ge, J. (2024) · mLife · doi:10.1002/mlf2.12110 · Cited by 30
“In addition to a chronic in fl ammatory response and abnormal metabolism of cholesterol, the onset and progression of atherosclerosis are also associated with the metabolism of bile acids 55 .”
BackgroundInterkingdom signaling between gastrointestinal hormones and the gut microbiome
Zhao, X., Qiu, Y., Liang, L., & Fu, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2456592 · Cited by 33
Li, J., Qiao, J., Li, Y., Qin, G., Xu, Y., Lao, K., Wang, Y., Yang, F., Tang, P., & Han, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1526468 · Cited by 38
“Among these, goose deoxycholic acid is a potent activator of the farnesoid receptor (44).”
Intermittent fasting—the future treatment in NASH patients?
Minciună, I., Gallage, S., Heikenwälder, M. F., Zelber‐Sagi, S., & Dufour, J. (2023) · Hepatology · doi:10.1097/hep.0000000000000330 · Cited by 31
Huang, Y., Xu, W., Dong, W., Chen, G., Sun, Y., & Zeng, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.027 · Cited by 37
“BAs are increasingly acknowledged for their pivotal role as metabolic regulators, governing lipid and glucose metabolisms through the activation of distinct signaling pathways [7,8].”
Fiaschini, N., Mancuso, M., Tanori, M., Colantoni, E., Vitali, R., Diretto, G., Lorenzo-Rebenaque, L., Stronati, L., & Negroni, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214254 · Cited by 31
Chu, C., Jiang, J., Yu, L., Li, Y. H., Zhang, S., Zhou, W., Wang, Q., Zhao, J., Zhai, Q., Tian, F., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.04.010 · Cited by 31
Sun, K., Zhu, N.-L., Huang, S., Qu, H. Y., Gu, Y., Li, Q., Liu, J., & Leng, Y. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01303-x · Cited by 29
Gillard, J., & Leclercq, I. A. (2023) · Clinical Science · doi:10.1042/cs20220697 · Cited by 29
Luo, Z., Du, Z., Huang, Y., Zhou, T., Wu, D., Yao, X., Shen, L., Yu, S., Yong, K., Wang, B., et al. (2024) · mSystems · doi:10.1128/msystems.00023-24 · Cited by 27
The bile–gut axis and metabolic consequences of cholecystectomy
Lange, A. H., Pedersen, M. G., Ellegaard, A., Nerild, H. H., Brønden, A., Sonne, D. P., & Knop, F. K. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae034 · Cited by 29
Xie, Y., Shao, X., Zhang, P., Zhang, H., Yu, J., Yao, X., Fu, Y., Wei, J., & Wu, C. (2024) · Metabolites · doi:10.3390/metabo14040236 · Cited by 30
“In general, bile acid synthesis is mainly regulated by two key rate-limiting enzymes ( CYP7A1 and CYP27A1 ) mediating the oxidation of cholesterol in hepatocytes [120,121].”
BackgroundJia, Y., Liu, Y., Wu, Y., Feng, C., Zhang, H., Ren, F., & Liu, H. (2024) · Food & Function · doi:10.1039/d4fo00585f · Cited by 27
Zhang, W., Wang, Y., Zhang, X., Zhang, Y., Yu, W., Tang, H., & Yuan, W. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03190-8 · Cited by 26
“(n = 6 biologically independent animals, means ± SD) energy expenditure in adipose tissue but also enhances glucose metabolism and insulin sensitivity, while regulating the anti-inflammatory responses of macrophages [24, 75–77].”
Luo, Z., Huang, Y., Yong, K., Wu, D., Zheng, L., Yao, X., Shen, L., Yu, S., Wang, B., & Cao, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2496437 · Cited by 28
“33 Bile acids are synthesized from cholesterol in the liver via both classical and alternative pathways, with the classical pathway predominantly producing 12-”
Microbial metabolite-receptor interactions in the gut microbiome
Chang, P. V. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102539 · Cited by 31
Regulation of intestinal immunity by dietary fatty acids
Qiu, J., Ma, Y., & Qiu, J. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00547-2 · Cited by 30
Bile salt signaling and bile salt-based therapies in cardiometabolic disease
Groenen, C., Nguyen, T.-A., Paulusma, C. C., & van de Graaf, S. F. J. (2024) · Clinical Science · doi:10.1042/cs20230934 · Cited by 25
Chemoproteomic profiling of substrate specificity in gut microbiota-associated bile salt hydrolases
Han, L., Pendleton, A., Singh, A., Xu, R., Scott, S. A., Palma, J. A., Diebold, P. J., Malarney, K. P., Brito, I., & Chang, P. V. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.05.009 · Cited by 26
Wang, Y., Yu, J., Chen, B., Jin, W., Wang, M., Chen, X., Jian, M., Sun, L., & Piao, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1481270 · Cited by 27
“BAs is a kind of amphiphilic steroid acid, whose production and diversity are in fl uenced by both host and microbial metabolism (3, 39).”
Wang, Y., Mei, P.-C., Bai, P.-R., An, N., He, J., Wang, J., Zhu, Q., & Feng, Y. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340691 · Cited by 23
Bile Acid Derivatives Effectively Prevented High‐Fat Diet‐Induced Colonic Barrier Dysfunction
Ma, Y., Shan, K., Huang, Z., Zhao, D., Zhang, M., Ke, W., & Li, C. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200649 · Cited by 26
Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
Rowe, J. C., & Winston, J. A. (2024) · Veterinary Sciences · doi:10.3390/vetsci11020094 · Cited by 26
Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases
Yang, S., Fu, J., Qin, W., Wang, R., Gu, M., Huang, Y., Liu, W., Su, H., Xu, X., Chen, W., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000957 · Cited by 23
An, G., Song, J., Ying, W., & Lim, W. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00521-6 · Cited by 25
“Within the enterohepatic circulation, bile acids serve as crucial signaling messengers that modulate metabolism in various tissues, primarily through the regulation of the farnesoid X receptor (FXR) and Takeda G-protein receptor 5 (TGR5) (Perino and Schoonjans 2022).”
Bile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon
Jalil, A., Perino, A., Dong, Y., Imbach, J., Volet, C., Oton, E. V., Demagny, H., Plantade, L., Gallart‐Ayala, H., Ivanišević, J., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00202-w · Cited by 25
“The signaling function of 7 α -dehydroxylated BAs relies on dedicated receptors (Perino and Schoonjans, 2022), such as Takeda-G-protein-receptor-5 (TGR5, GPBAR1) (Kawamata et al, 2003), whose activation drives host processes, including gut hormone secretion (Thomas et al, 2009; Kuhre et al, 2018; 1…”
Self-citationGu, S., Hu, S., Wang, S., Qi, C., Shi, C., & Fan, G. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2175671 · Cited by 21
Zhang, B., Wang, J., Chen, X., Xue, T., Xin, J., Liu, Y., Wang, X., & Li, X. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10365-1 · Cited by 21
“…leads to reduced activity in promoting GLP-1 secretion and reduced GLP-1 levels in the body, thereby resulting in reduced insulin secretion, increased glucagon secretion, increased gastric emptying and appetite, and decreased insulin sensitivity (Hu et al. 2021; Perino and Schoonjans 2022).”
Dong, Y., Chen, X., Abdelnaby, T., Guyonnet, V., Cai, X., & Wang, S. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c06148 · Cited by 23
Rebaudioside D decreases adiposity and hepatic lipid accumulation in a mouse model of obesity
Morissette, A., d’Oplinter, A. D. W., André, D. M., Lavoie, M., Marcotte, B., Varin, T. V., Trottier, J., Pilon, G., Pelletier, M., Cani, P. D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53587-y · Cited by 19
“Since BA has been shown to regulate energy homeostasis and lipid metabolism 37 , we next evaluated whether changes in BA-related genes and BA pool could be linked to the metabolic effects seen in mice administered RebA and RebD.”
Zhang, A., Gao, S., Shen, C., Wu, S., Wang, X., Shen, Q., Hua, J., Wang, J., Shi, J., Chen, S., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157092 · Cited by 19
The gut-liver axis in hepatobiliary diseases
Ichikawa, M., Okada, H., Nakamoto, N., Taniki, N., Chu, P., & Kanai∥, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-023-00315-0 · Cited by 19
“Through bile acid signaling, nuclear receptors such as FXR and G protein-coupled receptors (GPCRs) like Takeda-G-protein-receptor-5 (TGR5) regulate bile acid balance, lipid and sugar homeostasis, innate and acquired immunity [49–51].”
BackgroundGut microbiota induced abnormal amino acids and their correlation with diabetic retinopathy
Jiang, S., Huang, Y.-H., Ou, Y., Chen, K., Chen, J., & Tang, S. (2024) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.05.13 · Cited by 18
“Mounting literature reported that bile acids could suppress the growth of pathogenic bacteria [81-82] .”
BackgroundZhao, M., Kuang, W., Yang, J., Liu, Y., Yang, M., Chen, Y., Zhu, H., & Yang, Y. (2024) · Food & Function · doi:10.1039/d3fo04871c · Cited by 18
The Mediating Role of Bioactive Molecules in Gut Microbiota–Bone Metabolism Crosstalk
Liang, X., & Wang, L. (2025) · Nutrients · doi:10.3390/nu17213421 · Cited by 19
“Additionally, it disrupts the gut microbiota composition, alters the ratio of primary to secondary bile acids, and reduces the production of beneficial short-chain fatty acids such as butyrate [106,111].”
Wu, G., Wang, R., Wang, Y., Sun, S., Chen, J., & Zhang, Q. (2025) · Foods · doi:10.3390/foods14223836 · Cited by 17
“Approximately 5% of primary BAs are transformed into secondary BAs through metabolism by the gut microbiota, notably by Clostridium scindens within the Firmicutes phylum, via the action of 7 α -hydroxylase [97].”
Karlov, D. S., Long, S. L., Zeng, X., Xu, F., Lal, K., Cao, L., Hayoun, K., Lin, J., Joyce, S. A., & Tikhonova, I. G. (2023) · Structure · doi:10.1016/j.str.2023.02.014 · Cited by 17
Wang, S., Zhang, B., Chang, X., Zhao, H., Zhang, H., Zhao, T., & Qi, H. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2191135 · Cited by 19
“BAs are mainly converted from cholesterol in the liver and subsequently metabolized by bacteria in the intestine (Perino and Schoonjans 2022).”
Bile acid metabolism is altered in learning and memory impairment induced by chronic lead exposure
Liu, A., Li, Y., Li, L., Chen, K., Tan, M., Zou, F., Zhang, X., & Meng, X. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134360 · Cited by 18
Ren, X., Xu, Z., Guo, Y., Zhang, T., Li, B., Men, J., Han, J. Z., Yang, L., Zhou, Y., & Zhou, B. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c06926 · Cited by 15
Artificial Bear Bile: A Novel Approach to Balancing Medical Requirements and Animal Welfare
Li, Y., Huang, Y., Feng, N., Zhang, H., Qu, J., Ma, S., Liu, Y., Li, J., Xu, S., Wang, L., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.09.017 · Cited by 16
Psoriasis and gut microbes: research advances from mechanism to therapy
Chen, J., Sun, K., Zhang, X., Chen, X., Chu, Y., Geng, L., Bian, Z., Su, Y., Cong, X., & Wang, G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1711288 · Cited by 16
“BAs, produced in the liver and further modified in the intestine, play a pivotal role in lipid and fat-soluble vitamin digestion and absorption (Perino and Schoonjans, 2022).”
Zhang, Y., Huang, Y., Fan, J., Zhang, M., Hasan, A., Yang, Y., Yu, R., Zhou, X., Ye, M., & Qiao, X. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02086 · Cited by 14
Xiao, Y., Jia, Y., Liu, W., Niu, C., Mai, Z., Dong, J., Zhang, X.-S., Yuan, Z., Ji, P., Wei, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399829 · Cited by 14
Tran, Q. T., Sendler, M., Wiese, M. L., Doller, J., Zierke, L., Gischke, M., Glaubitz, J., Tran, V. H., Lalk, M., Bornscheuer, U. T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113592 · Cited by 14
“Bile acids (BAs), the largest component of bile juice, have recently gained attention for their pathological role in both rodents and humans [9].”
BackgroundBile Salt Hydrolase Activity‐Based Probes for Monitoring Gut Microbial Bile Acid Metabolism
Han, L., Xu, R., Conwell, A. N., Takahashi, S., Parasar, B., & Chang, P. V. (2024) · ChemBioChem · doi:10.1002/cbic.202300821 · Cited by 14
New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target
Xing, Y., Ou, Y., Wang, Y., Hou, L., & Zhu, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117284 · Cited by 13
Balancing cholesterol metabolism in the liver and gut: perspectives in health and disease
Yamauchi, Y., Sharpe, L. J., & Brown, A. J. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01168-3 · Cited by 15
Chen, H., Li, S., Pan, B., Liu, K., Yu, H., Ma, C., Qi, H., Zhang, Y., Huang, X., Ouyang, D., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1194401 · Cited by 12
“They are synthesized in the liver and mainly secreted into the gut, involving multiple bioactive processes including cholesterol, glucose and energy homeostasis (Perino and Schoonjans, 2022).”
BackgroundYang, B., Wen, F., & Cui, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70083 · Cited by 13
“The inhibition of bile acid biosynthesis is essential for HCC development and prognosis, 49 and targeting this pathway offers a promising therapeutic approach for managing this aggressive disease.”
BackgroundRowe, J. C., Summers, S., Quimby, J. M., & Winston, J. A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1458090 · Cited by 14
“It has been reported that other TGR5 agonists both inhibit development of kidney disease in murine models of obesity and diabetes (Wang et al., 2016), and more recently that a TGR5 agonist produced by the gut microbe Bacteroides fragilis can ameliorate renal fibrosis in both unilateral ureteral obstruction and adenine…”
BackgroundInfluentialDifferential roles of individual bile acid in physiology and disease
Fan, M., Yang, Z., Jin, L., & Huang, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107845 · Cited by 14
Zhao, W., Wang, H., Zheng, M., & Ni, Y. (2025) · Microbiome Research Reports · doi:10.20517/mrr.2025.12 · Cited by 13
Liu, Y., Yu, G., Medsker, H., Luo, T., Meng, X., Wang, C., Feng, L., & Zhang, J. (2024) · Environmental Research · doi:10.1016/j.envres.2024.119442 · Cited by 12
Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor
Qi, Y., Ma, Y., & Duan, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413656 · Cited by 13
“For exam‑ ple, activation of the FXR can influence the synthesis and secretion of insulin, while TGR5 activation can stimulate the release of glucagon‑like peptide‑1 (GLP‑1), thereby affecting blood glucose levels and energy expenditure [7,8].”
Shang, L., Zhao, M. Y., Hang, Y., Li, C., Yang, D., Zhang, M., Zhang, S., Wang, P., He, Z., & Gao, X. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125758 · Cited by 13
Ouyang, R., Zheng, S., Wang, X., Li, Q., Ding, J., Ma, X., Zhuo, Z., Li, Z., Qi, X., Lu, X., et al. (2023) · Metabolites · doi:10.3390/metabo13070846 · Cited by 14
Microbial Metabolites in Allergic Diseases: Beyond Short-Chain Fatty Acids
Morillas-Armenta, J., Macías‐Camero, A., Rzetecka, N., Zubeldia‐Varela, E., Barker‐Tejeda, T. C., Escribese, M. M., Pérez‐Gordo, M., Barber, D., & Villaseñor, A. (2025) · Current Allergy and Asthma Reports · doi:10.1007/s11882-025-01231-8 · Cited by 12
Li, J., Li, Z., Bao, Q., Chen, Y., Zhang, M., Tian, R., Yang, X., Liu, Z., Yao, Y., Lin, Q., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116859 · Cited by 11
Tan, Y., An, K., & Su, J. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.109925 · Cited by 11
Jiang, M., Zhang, X., Jin, X., Shi, B., Xu, Y., & Wang, Z. (2025) · Antioxidants · doi:10.3390/antiox14010045 · Cited by 13
Yue, S. R., Gong, L., Tan, Y. L., Zhang, X., & Liao, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114501 · Cited by 13
Shi, Q., Yuan, X. H., Xue, C., Gu, X., & Li, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108597 · Cited by 11
“Bile acids-farnesoid X receptor and bile acids-Takeda G-protein-coupled receptor-5 signaling pathways are closely associated with metabolic disorders, including Type 2 diabetes mellitus, non-alcoholic steatohepatitis, obesity, and atherosclerosis [10,11].”
BackgroundLiu, X., Xiao, C., Guan, P., Chen, Q., You, L., Kong, H., Qin, W., Dou, P., Li, Q., Li, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168308 · Cited by 10
“Bile acid receptors (TGR5 and FXR) distribute in multiple organs, including the liver, intestine, adipose tissues as well as immune cells (53).”
BackgroundUnderstanding the gastrointestinal tract in obesity: From gut motility patterns to enzyme secretion
Steenackers, N., Eksteen, G., Wauters, L. I., Augustijns, P., der Schueren, B. V., Vanuytsel, T., & Matthys, C. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14758 · Cited by 10
“121”
Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment
Gao, X., Zhang, F., Zhang, J., Ma, Y., Deng, Y., Chen, J., Ren, Y., Wang, H., Zhao, B., He, Y., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038862 · Cited by 9
Xu, W., Wang, Q., Yang, Y., Sun, S., Hui, Q., He, J., Jin, T., Yao, P., Wang, J., & Lin, F. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02640-2 · Cited by 9
Song, D., Zhang, A., Hu, X., Zeng, M., & Zhou, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154861 · Cited by 9
Fang, Y., Lv, S., Xiao, S., Hou, H., Yao, J., Cao, Y., He, B., Liu, X., Wang, P., Liu, D., et al. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142065 · Cited by 9
He, S., Peng, W.-B., Zhou, H., Fu, X., Sun, Y.-H., & Wang, Z. (2023) · Pharmaceuticals · doi:10.3390/ph16030462 · Cited by 8
Therapeutic Potential of Microbial Metabolites: New Insights and Perspectives
Hashmi, M. A. T. S., Khawar, M. B., Naseem, R., Afzal, A., Shahid, N., Abbasi, M. H., Sheikh, N., Afzal, N., Mukhtar, M., Shahzaman, S., et al. (2023) · Biomedical Research and Therapy · doi:10.15419/bmrat.v10i4.805 · Cited by 8
Metadata
- Authors
- Perino, A., & Schoonjans, K.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Schoonjans, Kristina
- Venue
- Nature Metabolism
- Published
- 2022-03-25
- Volume
- 4
- Issue
- 4
- Pages
- 416-423
- ISSN
- 2522-5812 (ISSN-L)
- OpenAlex
- W4221038382
- Cited by
- 223
- References
- 126
- Citations by year
- 2026: 54 · 2025: 63 · 2024: 61 · 2023: 32 · 2022: 13
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- AXA Research Fund
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF N° 310030_189178, CRSII5_180317/1)
- Stiftelsen Kristian Gerhard Jebsen
- École Polytechnique Fédérale de Lausanne
- "la Caixa" Foundation (HR17-00601)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- bile acids, bile acid receptors, farnesoid X receptor, TGR5, energy homeostasis, nutrient sensing, metabolic disorders, obesity, type 2 diabetes, nonalcoholic steatohepatitis, atherosclerosis, bile acid signaling
- MeSH terms
- Bile Acids and Salts, Biochemical Phenomena, Liver, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review